https://www.cleerlyhealth.com | United States | 2017 | $266.55M
Cleerly is a United States-based AI technology company specializing in early detection and prevention of heart disease. Its flagship product, Cleerly ISCHEMIA, is an FDA-cleared software analyzing coronary CT scans to detect plaque buildup, improving diagnostic certainty and personalized treatment planning. Cleerly’s solutions have been validated through clinical trials and the company has partnered with healthcare organizations to expand access to its technology.
